Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin for Thumb CMC Arthritis
NCT05990881Phase 3Recruiting
- Sponsor
- Rhode Island Hospital
- Start
- Aug 2023
- Primary completion
- Dec 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in osteoarthritis of the thumb carpometacarpal joint, sponsored by Rhode Island Hospital. Started Aug 2023; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
osteoarthritis of the thumb carpometacarpal joint
Beyond the preview
Go deeper on NCT05990881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05990881.